Not exact matches
The NASEM report, commissioned by Congress in 2016, collected career aspiration, training, and outcome data from NIH,
research institutions, and professional societies, as well as solicited suggestions from individual university administrators and
biomedical scientists at different stages of their careers.The report
especially zeroed in on the plight of the postdoctoral
research fellow.
«A lot of things are happening at a very fast pace,» says Jackie Ying, who was a professor for 11 years at MIT in Cambridge, Massachusetts, before moving to Singapore in 2003 as executive director of the Institute for Bioengineering and Nanotechnology, «and Singapore has tremendous
research opportunities,
especially in the
biomedical areas.»
He said that partnership, created after World War II, is no longer working properly,
especially with respect to
biomedical research — the «800 - pound gorilla» in the room.
The U.S. National Institutes of Health (NIH) has a long history of working to increase the diversity of its intramural and extramural
biomedical research workforce, especially through programs such as Minority Access to Research Careers, Minority Biomedical Research Support, Research Centers at Minority Institutions, and Diversity Supp
research workforce,
especially through programs such as Minority Access to
Research Careers, Minority Biomedical Research Support, Research Centers at Minority Institutions, and Diversity Supp
Research Careers, Minority
Biomedical Research Support, Research Centers at Minority Institutions, and Diversity Supp
Research Support,
Research Centers at Minority Institutions, and Diversity Supp
Research Centers at Minority Institutions, and Diversity Supplements.
Yeatman says that
biomedical research is also ripe for renewal,
especially in areas such as osteoporosis and protein crystallography.
«In the United States, since World War II when this basic system was created,
research has been a kind of Ponzi scheme in the sense that when the government provides grants, the institution leverages the indirect costs to expand
research... and no institution has the resources to support the size of the faculty they have,
especially in the
biomedical sciences.»
«We... support federal investment in basic and applied
biomedical research,» it says, «
especially the neuroscience
research that may hold great potential for dealing with diseases and disorders such as Autism, Alzheimer's, and Parkinson's.»
The advanced capabilities now available in CoMet are
especially relevant to the needs of
biomedical research, clinical practice, natural product management, and environmental studies.
As a citizen of the United States and a taxpayer, and as a practicing
biomedical applied statistician, I am
especially concerned about the possibility that the funding garnered for such potentially flawed studies is detracting from other groups» ability to obtain funding to perform valid
research in the valuable arena of personalized medicine.